Bengaluru-based health-tech startup Dozee, backed by Prime Venture Partners and 3one4 Capital, has raised Rs 71.5 crore (approximately $8.3 million) through a mix of equity and debt.
According to the startup’s MCA filings, Temasek Trust’s impact-first investment vehicle C3H invested Rs 6.3 crore in equity, while Stockhausen International Pte Ltd provided Rs 58.5 crore as debt. The remaining funds came from undisclosed strategic investors.
The fresh capital will accelerate Dozee’s global expansion and enhance its R&D efforts to improve critical patient care monitoring, a company spokesperson confirmed.
Founded in 2015 by Mudit Dandwate and Gaurav Parchani, Dozee specializes in contactless patient monitoring systems, enabling hospitals to remotely track vital signs such as heart rate, respiration rate, blood pressure, and temperature. The company also offers an early warning system that alerts doctors to potential health deterioration in patients.
Dozee competes with Zyla Health, Fix Health, Zivov, and Cardiac Design Labs in the Indian health-tech space.
The startup last raised $6 million in a Series A2 round in 2023 from 3one4 Capital, Prime Venture Partners, YourNest VC, and the State Bank of India, among others. With this latest round, Dozee’s total funding now nears $20 million.
Facing growth challenges in India, Dozee has expanded to the US, UAE, and Africa and is actively exploring new international markets while broadening its product portfolio.
The company is also hiring across multiple departments, including data science, product, and marketing, as it aims to achieve profitability in India. However, last year, Dozee laid off around 40 employees to reduce losses.
